Dual orexin receptor antagonists for treatment of insomnia: A systematic review and meta-analysis on randomized, double-blind, placebo-controlled trials of suvorexant and lemborexant

STUDY OBJECTIVES: Recent treatment guidelines for chronic insomnia recommend pharmacological and non-pharmacological therapies. One of the contemporary drug options for insomnia includes dual orexin receptor antagonist (DORA), such as suvorexant and lemborexant. We conducted a systematic review and...

Descripción completa

Detalles Bibliográficos
Autores principales: Khazaie, Habibolah, Sadeghi, Masoud, Khazaie, Sepideh, Hirshkowitz, Max, Sharafkhaneh, Amir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792135/
https://www.ncbi.nlm.nih.gov/pubmed/36578296
http://dx.doi.org/10.3389/fpsyt.2022.1070522

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792135/
https://www.ncbi.nlm.nih.gov/pubmed/36578296
http://dx.doi.org/10.3389/fpsyt.2022.1070522

Ejemplares similares